- Home
- RNAZ vs LEDS Comparison
RNAZ vs LEDS Comparison
Compare RNAZ & LEDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- LEDS
- Stock Information
- Founded
- RNAZ 2016
- LEDS 2005
- Country
- RNAZ United States
- LEDS Taiwan
- Employees
- RNAZ N/A
- LEDS N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- LEDS Semiconductors
- Sector
- RNAZ Health Care
- LEDS Technology
- Exchange
- RNAZ Nasdaq
- LEDS Nasdaq
- Market Cap
- RNAZ 8.3M
- LEDS 8.9M
- IPO Year
- RNAZ 2021
- LEDS 2010
- Fundamental
- Price
- RNAZ $0.34
- LEDS $1.24
- Analyst Decision
- RNAZ Strong Buy
- LEDS
- Analyst Count
- RNAZ 1
- LEDS 0
- Target Price
- RNAZ $3.00
- LEDS N/A
- AVG Volume (30 Days)
- RNAZ 606.0K
- LEDS 690.5K
- Earning Date
- RNAZ 11-26-2024
- LEDS 01-10-2025
- Dividend Yield
- RNAZ N/A
- LEDS N/A
- EPS Growth
- RNAZ N/A
- LEDS N/A
- EPS
- RNAZ N/A
- LEDS N/A
- Revenue
- RNAZ N/A
- LEDS $5,312,000.00
- Revenue This Year
- RNAZ N/A
- LEDS N/A
- Revenue Next Year
- RNAZ $100.00
- LEDS N/A
- P/E Ratio
- RNAZ N/A
- LEDS N/A
- Revenue Growth
- RNAZ N/A
- LEDS N/A
- 52 Week Low
- RNAZ $0.22
- LEDS $0.92
- 52 Week High
- RNAZ $18.68
- LEDS $2.29
- Technical
- Relative Strength Index (RSI)
- RNAZ 33.05
- LEDS 50.88
- Support Level
- RNAZ $0.31
- LEDS $1.09
- Resistance Level
- RNAZ $0.49
- LEDS $1.94
- Average True Range (ATR)
- RNAZ 0.05
- LEDS 0.16
- MACD
- RNAZ -0.02
- LEDS 0.01
- Stochastic Oscillator
- RNAZ 12.67
- LEDS 20.00
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufacture, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, that includes street lights and commercial, industrial, system and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from the United States.